Visit-to-Visit Systolic Blood Pressure Variability Independently Predicts Cardiovascular Events in a Kidney Transplant Recipients' Cohort.

blood pressure variability cardiovascular outcome cardiovascular risk kidney transplantation

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
16 Jul 2024
Historique:
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 16 7 2024
Statut: aheadofprint

Résumé

The predictive role of blood pressure variability for all-cause mortality and fatal and nonfatal cardiovascular events has been described in the general population and in patients with diabetes, independently of mean BP. Although systolic blood pressure variability has been proposed as an informative measure for predicting clinical outcomes in patients with chronic kidney disease, its role in kidney transplant recipients is still debatable. We performed a retrospective, observational, monocentric analysis of all kidney transplant recipients in follow-up at the outpatient Nephrology Clinic of San Martino Hospital from January 1, 2016 to December 31, 2016, who underwent kidney transplantation >12 months. The primary outcome was a fatal or nonfatal cardiovascular event (myocardial infarction, unstable angina, stroke, and hospitalization for heart failure). Visit-to-visit systolic blood pressure variability was expressed as the SD of systolic blood pressure values recorded at baseline and 3 months up to 18 months. Among the 272 patients (mean age, 64±13; 63% men) included in the present analyses, for each increase of 2.7 mm Hg in systolic blood pressure SD, the risk for events increased 3-fold (hazard ratio [HR], 3.1 [95% CI, 1.19-7.88]; Long-term blood pressure variability represents a risk factor for cardiovascular events in kidney transplant recipients, even independently by several confounding factors including blood pressure load.

Sections du résumé

BACKGROUND BACKGROUND
The predictive role of blood pressure variability for all-cause mortality and fatal and nonfatal cardiovascular events has been described in the general population and in patients with diabetes, independently of mean BP. Although systolic blood pressure variability has been proposed as an informative measure for predicting clinical outcomes in patients with chronic kidney disease, its role in kidney transplant recipients is still debatable.
METHODS AND RESULTS RESULTS
We performed a retrospective, observational, monocentric analysis of all kidney transplant recipients in follow-up at the outpatient Nephrology Clinic of San Martino Hospital from January 1, 2016 to December 31, 2016, who underwent kidney transplantation >12 months. The primary outcome was a fatal or nonfatal cardiovascular event (myocardial infarction, unstable angina, stroke, and hospitalization for heart failure). Visit-to-visit systolic blood pressure variability was expressed as the SD of systolic blood pressure values recorded at baseline and 3 months up to 18 months. Among the 272 patients (mean age, 64±13; 63% men) included in the present analyses, for each increase of 2.7 mm Hg in systolic blood pressure SD, the risk for events increased 3-fold (hazard ratio [HR], 3.1 [95% CI, 1.19-7.88];
CONCLUSIONS CONCLUSIONS
Long-term blood pressure variability represents a risk factor for cardiovascular events in kidney transplant recipients, even independently by several confounding factors including blood pressure load.

Identifiants

pubmed: 39011950
doi: 10.1161/JAHA.124.034108
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e034108

Auteurs

Elisabetta Bussalino (E)

Clinic of Nephrology, Dialysis and Transplant IRCCS Ospedale Policlinico San Martino Genoa Italy.
Department of Internal Medicine and Medical Specialties University of Genoa Genoa Italy.

Daniela Picciotto (D)

Clinic of Nephrology, Dialysis and Transplant IRCCS Ospedale Policlinico San Martino Genoa Italy.

Lucia Macciò (L)

Clinic of Nephrology, Dialysis and Transplant IRCCS Ospedale Policlinico San Martino Genoa Italy.
Department of Internal Medicine and Medical Specialties University of Genoa Genoa Italy.

Angelica Parodi (A)

Clinic of Nephrology, Dialysis and Transplant IRCCS Ospedale Policlinico San Martino Genoa Italy.

Maria Teresa Gandolfo (MT)

Clinic of Nephrology, Dialysis and Transplant IRCCS Ospedale Policlinico San Martino Genoa Italy.

Francesca Viazzi (F)

Clinic of Nephrology, Dialysis and Transplant IRCCS Ospedale Policlinico San Martino Genoa Italy.
Department of Internal Medicine and Medical Specialties University of Genoa Genoa Italy.

Classifications MeSH